Scedosporium boydii CatA1 and SODC recombinant proteins, new tools for serodiagnosis of Scedosporium infection of patients with cystic fibrosis

被引:13
作者
Mina, Sara [1 ,2 ]
Staerck, Cindy [1 ]
Marot, Agnes [1 ]
Godon, Charlotte [1 ]
Calenda, Alphonse [1 ]
Bouchara, Jean-Philippe [1 ,3 ]
Fleury, Maxime J. J. [1 ]
机构
[1] Univ Bretagne Loire, UNIV Brest, UNIV Angers, Grp Etud Interact Hote Pathogene,EA 3142, Angers, France
[2] Beirut Arab Univ, Fac Hlth Sci, Beirut, Lebanon
[3] CHU Angers, Lab Parasitol Mycol, Angers, France
关键词
Scedosporium species; Cystic fibrosis; Serodiagnosis; Catalase; Cu; Zn superoxide dismutase; recombinant proteins; CU; ZN SUPEROXIDE-DISMUTASE; PSEUDALLESCHERIA-BOYDII; ASPERGILLUS-FUMIGATUS; TRANSPLANT RECIPIENTS; APIOSPERMUM INFECTION; IDENTIFICATION; CATALASE; PREVALENCE; ANTIGENS; THERAPY;
D O I
10.1016/j.diagmicrobio.2017.08.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Scedosporium species rank the second among the filamentous fungi colonizing the airways of patients with cystic fibrosis (CF), after Aspergillus fumigatus. In CF, these fungi may cause various respiratory infections similar to those caused by A. fumigatus, including bronchitis and allergic broncho-pulmonary mycoses. Diagnosis of these infections relies on the detection of serum antibodies using crude antigenic extracts. However, many components of these extracts are common to Scedosporium and Aspergillus species, leading to cross-reactions. Here, 5 recombinant proteins from S. apiospermum or S. boydii were produced, and their value in serodiagnosis of Scedosporium infections was investigated by enzyme-linked immunosorbent assay. Two of them, corresponding to the Scedosporium catalase Al or cytosolic Cu,Zn-superoxyde dismutase, allowed the detection of Scedosporium infection, and the differentiation with an Aspergillus infection. These recombinant proteins therefore may serve as a basis for the development of a standardized serological test. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:282 / 287
页数:6
相关论文
共 49 条
  • [1] Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates
    Alastruey-Izquierdo, Ana
    Cuenca-Estrella, Manuel
    Monzon, Araceli
    Rodriguez-Tudela, Juan L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 748 - 751
  • [2] Novel immunologic classification of aspergillosis in adult cystic fibrosis
    Baxter, Caroline G.
    Dunn, Graham
    Jones, Andrew M.
    Webb, Kevin
    Gore, Robin
    Richardson, Malcolm D.
    Denning, David W.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (03) : 560 - +
  • [3] BIGUET J, 1967, REV IMMUNOL, V31, P317
  • [4] Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?
    Blyth, Christopher C.
    Middleton, Peter G.
    Harun, Azian
    Sorrell, Tania C.
    Meyer, Wieland
    Chen, Sharon C. -A.
    [J]. MEDICAL MYCOLOGY, 2010, 48 : S37 - S44
  • [5] Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi
    Borman, Andrew M.
    Palmer, Michael D.
    Delhaes, Laurence
    Carrere, Jacqueline
    Favennec, Loic
    Ranque, Stephane
    Gangneux, Jean-Pierre
    Horre, Regine
    Bouchara, Jean-Philippe
    [J]. MEDICAL MYCOLOGY, 2010, 48 : S88 - S97
  • [6] Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods
    Castanheira, Mariana
    Duncanson, Frederick P.
    Diekema, Daniel J.
    Guarro, Josep
    Jones, Ronald N.
    Pfaller, Michael A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (01) : 352 - 357
  • [7] Pseudallescheria boydii (anamorph Scedosporium apiospermum) infection in solid organ transplant recipients in a tertiary medical center and review of the literature
    Castiglioni, B
    Sutton, DA
    Rinaldi, MG
    Fung, J
    Kusne, S
    [J]. MEDICINE, 2002, 81 (05) : 333 - 348
  • [8] CHABASSE D, 1991, Journal de Mycologie Medicale, V1, P152
  • [9] Cimon B, 1995, J MYCOL MED, V5, P211
  • [10] Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis
    Cimon, B
    Carrère, J
    Vinatier, JF
    Chazalette, JP
    Chabasse, D
    Bouchara, JP
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (01) : 53 - 56